Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: J Immunol. 2013 Jan 4;190(3):1135–1147. doi: 10.4049/jimmunol.1201455

Figure 7.

Figure 7

(A) IFN-γ CD8+ T cell responses to predicted minimal epitopes from the MSP133 Wellcome allele. Volunteers and time-points tested are equivalent to those in Figure 6. HLA-B*1801 is heterozygous in volunteers, #1 and #14 and homozygous in volunteer #7. Complete epitope sequences, predicted HLA associations, and equivalent trial peptide location for all minimal epitopes can be found in Table II. (B) IFN-γ CD8+ T cell responses from volunteer #7 to 20mer peptides containing minimal epitopes recognized previously. (C) Location of CD8+ T cell minimal epitopes recognized by volunteers with HLA-B*1801. Epitopes are located towards the N-terminus of the Wellcome MSP133 fragment.